Belotecan news

All news on Belotecan (also known as CKD-602 and Camtobell): plants, production capacities, investments and involved companies.

18 May 2026

Merck: sac‑TMT meets OS and PFS endpoints in Phase 3 TroFuse‑005 for advanced/recurrent endometrial cancer

TroFuse‑005 (776 pts) showed significant OS and PFS improvement vs chemotherapy in advanced/recurrent endometrial cancer after platinum and anti‑PD‑1/PD‑L1 therapy; ORR met; safety consistent.

Who will be producing Belotecan in the future?

Find out with chemXplore Alpha

Learn more